If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWise Group Regulatory News (WISE)

Share Price Information for Wise Group (WISE)

Share Price is delayed by 15 minutes
Get Live Data
963.00    2.40 (0.25%)
Bid:
965.00
Ask:
968.00
Spread: 3.00 (0.311%)
Market Cap: £9.51b
WISE Live PriceLast checked at - London Stock Exchange

Intraday Wise Group Share Chart

Regulatory Approval

25 Nov 2021 15:47

RNS Number : 6442T
Wise PLC
25 November 2021
 

Wise PLC

25 November 2021

 

 

Approval for the removal of voting caps

 

 

As disclosed in Wise's prospectus in respect of its listing on the London Stock Exchange in July 2021 (the "Prospectus") , and as set out in Wise's articles of association (the "Articles"), there are certain caps in respect of the number of votes that each group of class B ordinary shareholders is entitled to exercise by virtue of its consolidated holding of class B ordinary shares. Pursuant to the Articles, such voting caps are set in respect of all class B ordinary shareholder groups at one vote below 25% of the aggregate number of votes attaching to shares eligible to be case in respect of each shareholder resolution until such time as:

(i) the mandatory regulatory approval required from the Hong Kong Customers and Excise Department with respect to the control of issued share capital, voting rights, and/or management of Wise has been granted;

(ii) the mandatory regulatory approvals required from the U.S. states of New York and Virginia with respect to the control of issued share capital, voting rights, and/or management of Wise has been granted; and

(iii) the satisfaction of conditions (i) and (ii) above has been confirmed by a resolution of Wise's board of directors.

 

Wise today announces the satisfaction of the conditions set out above. As a result (pursuant to the Articles and as disclosed in the Prospectus), the voting caps in respect of class B ordinary shareholders have been increased as follows:

- the number of votes that each class B ordinary shareholder group (other than Kristo Käärmann's class B ordinary shareholder group) is entitled to exercise by virtue of its consolidated holding of class B ordinary shares shall be capped at one vote below 35% of the aggregate number of votes attaching to shares eligible to be cast in respect of each shareholder resolution; and

- the number of votes that Kristo Käärmann's class B ordinary shareholder group is entitled to exercise by virtue of its consolidated holding of class B ordinary B ordinary shares shall be capped at one vote below 50% of the aggregate number of votes attaching to shares eligible to be cast in respect of each shareholder resolution.

 

As a result of this increase in voting cap, Wise's CEO and Co-Founder, Kristo Käärmann, shall, by virtue of his class B ordinary shareholder group's shareholding as of the date of this announcement, be entitled to 41.1% of the voting rights in respect of shareholder decisions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
READZMZMKKKGMZM
Date   Source Headline
3rd Dec 20244:41 pmRNSDirector/PDMR Shareholding
2nd Dec 20243:52 pmRNSTotal Voting Rights
7th Nov 20244:04 pmRNSDirector/PDMR Shareholding
6th Nov 20247:00 amRNSUnaudited interim results for period ended 30/9/24
1st Nov 20241:23 pmRNSTotal Voting Rights
28th Oct 20247:00 amRNSFCA concludes investigation into Kristo Käärmann
16th Oct 202411:35 amRNSDirector/PDMR Shareholding
15th Oct 20247:00 amRNSQ2 Trading Update
1st Oct 20245:20 pmRNSTotal Voting Rights
18th Sep 20244:58 pmRNSResult of AGM
3rd Sep 202410:22 amRNSTotal Voting Rights
28th Aug 20247:00 amRNSDirector/PDMR Shareholding
19th Aug 20243:33 pmRNSDirector/PDMR Shareholding
14th Aug 202412:36 pmRNSDirector/PDMR Shareholding
12th Aug 20247:00 amRNSBlock listing Interim Review
9th Aug 20249:24 amRNSNotice of AGM
8th Aug 202410:21 amRNSHolding(s) in Company
1st Aug 202410:30 amRNSTotal Voting Rights
29th Jul 202412:50 pmRNSPDMR Shareholding
24th Jul 202410:47 amRNSDirector/PDMR Shareholding
19th Jul 20243:39 pmRNSDirector/PDMR Shareholding
17th Jul 20243:04 pmRNSDirector/PDMR Shareholding
16th Jul 20247:00 amRNS1st Quarter Results
12th Jul 20241:16 pmRNSAnnual Financial Report
5th Jul 20241:55 pmRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSTotal Voting Rights
19th Jun 20245:11 pmRNSDirector/PDMR Shareholding
19th Jun 20241:56 pmRNSDirector/PDMR Shareholding
18th Jun 20247:00 amRNSDirector/PDMR Shareholding
14th Jun 202412:18 pmRNSDirector/PDMR Shareholding
13th Jun 20247:00 amRNSWISE PLC PRELIMINARY RESULTS FY END 31 MARCH 2024
3rd Jun 20244:36 pmRNSTotal Voting Rights
29th May 202410:39 amRNSPresentation of financial information
2nd May 202410:02 amRNSTotal Voting Rights
26th Apr 20244:01 pmRNSDirector/PDMR Shareholding
24th Apr 20244:32 pmRNSDirector/PDMR Shareholding
22nd Apr 20243:12 pmRNSDirector/PDMR Shareholding
22nd Apr 20247:00 amRNSDirector/PDMR Shareholding
18th Apr 20249:33 amRNSHolding(s) in Company
17th Apr 20247:00 amRNSDirector/PDMR Shareholding
16th Apr 20243:03 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSWISE PLC Q4FY24 TRADING UPDATE
25th Mar 20247:00 amRNSManagement Update
15th Mar 202412:43 pmRNSHolding(s) in Company
15th Mar 202412:35 pmRNSTotal Voting Rights
1st Mar 20242:03 pmRNSTotal Voting Rights
6th Feb 20245:08 pmRNSDirector/PDMR Shareholding
2nd Feb 20249:22 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
30th Jan 202412:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.